Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to ...
A York biotech company has announced a major move that may see easier and quicker detection of lung cancer in the UK.
Arena launched with $500 million in early 2024 to fund basic biological research, from which it planned to spin out dedicated ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
Novo Nordisk CEO Mike Doustdar joins 'Squawk Box' to discuss the company's quarterly earnings results, the company's bid for ...
Man arrested for illegally transporting 1,000 kg of PDS rice in Hyderabad; investigation ongoing to uncover broader racket.
24/7 Wall St. on MSN
Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More
In the past week or so, beneficial owners took advantage of MapLight Therapeutics Inc.’s (NASDAQ: MPLT) initial public ...
Swiss pharma giant Novartis has been on a deal spree ahead of several major patent expiries. In late October it agreed a $12 ...
Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback